Nikolaus Matuschka - ACS Actividades CEO AG
| ACSAF Stock | USD 45.33 0.00 0.00% |
Insider
Nikolaus Matuschka is CEO AG of ACS Actividades de
| Age | 60 |
| Phone | 34 91 343 92 00 |
| Web | https://www.grupoacs.com |
ACS Actividades Management Efficiency
The company has return on total asset (ROA) of 0.0378 % which means that it generated a profit of $0.0378 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.167) %, meaning that it generated substantial loss on money invested by shareholders. ACS Actividades' management efficiency ratios could be used to measure how well ACS Actividades manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Cui Sun | China Railway Group | 57 | |
| Xiaohui Wang | iQIYI Inc | 55 | |
| Moshe Mizrahy | InMode | 71 | |
| Yun Chen | China Railway Group | 60 | |
| Timothy Pigot | Aerovate Therapeutics | 53 | |
| Chang Yu | iQIYI Inc | N/A | |
| Kris Wu | iQIYI Inc | N/A | |
| James Hom | SoundHound AI | 40 | |
| Michael Kreindel | InMode | 56 | |
| George Eldridge | Aerovate Therapeutics | 61 | |
| Nava TalLauner | InMode | ||
| MBA MR | Aerovate Therapeutics | 62 | |
| Xinsheng Li | China Railway Group | 43 | |
| Timothy MBA | Aerovate Therapeutics | 62 | |
| Wen He | China Railway Group | 58 | |
| Benjamin Dake | Aerovate Therapeutics | 48 | |
| Tim Yu | iQIYI Inc | 55 | |
| Hunter MD | Aerovate Therapeutics | 58 | |
| Michael Zagorsek | SoundHound AI | 48 | |
| Lisa Flattery | SoundHound AI | N/A | |
| Jun Wang | iQIYI Inc | 45 | |
Management Performance
| Return On Equity | -0.17 | |||
| Return On Asset | 0.0378 |
ACS Actividades de Leadership Team
Elected by the shareholders, the ACS Actividades' board of directors comprises two types of representatives: ACS Actividades inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ACS. The board's role is to monitor ACS Actividades' management team and ensure that shareholders' interests are well served. ACS Actividades' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ACS Actividades' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Angel Altozano, Corporate General Director | ||
| Juan Cases, CEO of Iridium, Concesiones de Infraestructuras, S.A. | ||
| Nuria Haltiwanger, Concesiones Iridium | ||
| Peter Davoren, Chairman and CEO of Turner Construction | ||
| Eugenio Gmez, Comunicaciones Servicios | ||
| Nikolaus Matuschka, CEO AG | ||
| Florentino Rodrguez, Ex Chairman | ||
| Adolfo Martnez, Chairman Flatiron | ||
| Cristbal Alvarado, Chief Clece | ||
| LLB LLB, Gen Director |
ACS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is ACS Actividades a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.17 | |||
| Return On Asset | 0.0378 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 8.36 B | |||
| Shares Outstanding | 262.57 M | |||
| Shares Owned By Insiders | 20.86 % | |||
| Shares Owned By Institutions | 24.11 % | |||
| Price To Earning | 11.05 X | |||
| Price To Book | 1.22 X |
Currently Active Assets on Macroaxis
Other Information on Investing in ACS Pink Sheet
ACS Actividades financial ratios help investors to determine whether ACS Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ACS with respect to the benefits of owning ACS Actividades security.